I am excited to connect with you through this July 2015 edition of Oviya MedSafe’s newsletter, which has been designed to be your ready reckoner of information on the global pharmacovigilance events that Team Oviya MedSafe will be a part of, in the months to come!
At the 4th International Conference and Exhibition on Pharmacovigilance & Clinical Trials to be conducted by OMICS International at London, UK on the 10th, 11th and 12th of August 2015, Oviya MedSafe’s UK Business Advisor Mr Alistair J Coates will deliver a keynote address on the topic ‘European Pharmacovigilance under EudraVigilance and the eXtended Eudravigilance Medicinal Products Dictionary (XEVMPD) environment within it’. I am confident that the mention of this topic is by itself enough to make you think of attending this conference.
On 2nd September 2015, we would look forward to meeting you at the 9th Pharmacovigilance 2015 conference that will be organized by Virtue Insight at Mumbai, India. Further, on 9th September 2015, Oviya MedSafe in association with Assured Information Systems, UK (part of Ennov Group) would conduct a webinar titled “Why pharmaceutical companies are in a dire need of building an innovative and efficient pharmacovigilance system for Indian compliance”, from 3 PM to 4 PM India Time (9:30 AM to 10:30 AM GMT). Please contact us directly for the agenda and the registration procedure for this free webinar.
On October 19th 2015, I will chair EasyB’s UK Pharmacovigilance Day 2015 conference at London, UK and conduct the day’s proceedings along with Dr Sumit Munjal, Medical Director Lead, Global Pharmacovigilance at Takeda Pharmaceuticals, UK. I would also participate in the 10th Annual Conference of the Pharmaceutical Information & Pharmacovigilance Association (PIPA), UK and hope to get the opportunity to meet drug safety colleagues from all over the European Union during these conferences.
In November 2015, I will be in Singapore to speak on ‘Exploiting Social Media to Identify Potential Safety Signals and to Augment Adverse Event Data Collection’ and be part of a panel discussion titled ‘Overcoming Challenges in PV in Developing Asia’, in the 6th Annual Pharmacovigilance Asia 2015 conference which has been organized by IQPC on 18th and 19th November 2015. I am proud to state that IQPC has invited Oviya MedSafe as an event partner for this conference.
The Singapore event is further significant for Oviya MedSafe due to the fact that my colleagues and I will be presenting a post-conference workshop on 20-Nov-2015 titled ‘Case Narrative Writing for Reporting Adverse Events’, leveraging Oviya MedSafe’s rich experience in writing and reviewing various types of narratives for Individual Case Safety Reports (ICSRs) and Clinical Study Reports (CSRs). Please go through the event agenda and click here to register for the conference.
I take this opportunity to request you to try your best to attend the above-mentioned events and join us in our aspiration to teach and learn from such knowledge-sharing occasions.
Apart from the above, you may be able to meet us at some other events too, about which I will share in our newsletter’s August 2015 edition.
Signing off for now, to meet you with more descriptive news next month,
With thanks & regards,
Dr J Vijay Venkatraman
MBBS, F. Diab., MBA., FPIPA (UK)
Managing Director & CEO,
Pharmacovigilance Consulting & Drug Safety Services
Coimbatore, India & London, UK
India Office: +91-422-2444442
UK Office: +44-8452-733839
Google Plus: plus.google.com/109414464810448488118/posts